Repligen | RGEN - المديونيات المتداولة

سعر السهم
117.60
التغيير اليومي
3.54 3.10%
شهريا
2.87%
سنويا
-18.76%
Q2 التوقعات
115.08




المديونيات المتداولة تغيير تاريخ
Agilent USD 2.23B 113M 2025-12
Align Technology USD 1.92B 46.45M 2025-12
Bio Techne USD 140.43M 4.12M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Bruker USD 1.28B 11.1M 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.34B 62M 2025-12
General Electric Aerospace USD 40.03B 1.05B 2026-03
Henry Schein USD 3.23B 79M 2025-12
Illumina USD 1.59B 377M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Mettler Toledo International USD 1.2B 5.99M 2025-12
Myriad Genetics USD 133.8M 14.2M 2025-12
OraSure Technologies USD 39.8M 453K 2025-12
Pacific Biosciences Of California USD 72.83M 9.62M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Repligen USD 135.83M 4.69M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Standard Biotools USD 108.31M 343K 2025-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 674M 19.1M 2026-03